Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics (Q39763097)

14 September 2017

title

Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics (English)

1 reference

14 September 2017

Britta Haenisch

1

1 reference

14 September 2017

Heinz Bönisch

series ordinal

2

1 reference

14 September 2017

publication date

10 December 2009

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

381

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

33-39

1 reference

Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes

14 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-009-0479-8

Expression and immunolocalization of the plasma membrane monoamine transporter in the brain

21 January 2018

1 reference

12 December 2020

Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain

1 reference

12 December 2020

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

12 December 2020

3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine

1 reference

12 December 2020

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

1 reference

12 December 2020

The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia.

1 reference

12 December 2020

The norepinephrine transporter in physiology and disease.

1 reference

12 December 2020

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model

1 reference

12 December 2020

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

1 reference

12 December 2020

Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus

1 reference

12 December 2020

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

1 reference

12 December 2020

Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Determination of selected phenothiazines in human plasma by solid-phase extraction and liquid chromatography with coulometric detection

1 reference

12 December 2020

Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells

1 reference

12 December 2020

The localisation of the extraneuronal monoamine transporter (EMT) in rat brain

1 reference

12 December 2020

Identification and characterization of a novel monoamine transporter in the human brain

1 reference

12 December 2020

Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy

1 reference

12 December 2020

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain

1 reference

12 December 2020

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

1 reference

12 December 2020

Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter

1 reference

12 December 2020

Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

1 reference

12 December 2020

Interaction of organic cations with a newly identified plasma membrane monoamine transporter

1 reference

12 December 2020

The uptake and O-methylation of 3H-(�)-isoprenaline in rat cerebral cortex slices

1 reference

12 December 2020

Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain

1 reference

12 December 2020

Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors

1 reference

12 December 2020

Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Drug excretion mediated by a new prototype of polyspecific transporter

1 reference

12 December 2020

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

1 reference

12 December 2020

Development of a population pharmacokinetic database for tianeptine

1 reference

12 December 2020

The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart

1 reference

12 December 2020

Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference

1 reference

12 December 2020

10.1007/S00210-009-0479-8

Identifiers

DOI

1 reference

14 September 2017

1 reference